“…Given the potential role of RUNX3 in TGF-b signaling, it is possible that the tumor suppressor activity of RUNX3 is realized by regulating cell migration and invasion . More and more studies during recent years discovered that RUNX3 inactivation is a crucial factor to determine cancer pathogenesis and clinical outcome in a variety of cancer types, such as gastric, colonic, prostate, breast, lung and bladder cancers (Araki et al, 2005;Suzuki et al, 2005;Ogino et al, 2007;Jiang et al, 2008;Hsu et al, 2009;Wongpaiboonwattana W et al, 2013). It was also reported in esophageal cancer (Sugiura et al, 2008).…”